Healthcare-software company Waystar has agreed to buy private-equity backed Iodine Software for $1.25 billion, including debt. The transaction was announced Wednesday afternoon, confirming a prior report by The Wall Street Journal. Waystar will fund the deal with an equal mix of cash and stock.